Allez à nos transactions
Soins de la Santé

ZoomMed Inc. has sold certain assets to TELUS Health

TELUS Health, Canada’s largest Electronic Medical Records (EMR) provider and a leader in the Canadian claims and benefits management sector, is adding important new functionality to its existing health technology portfolio through its acquisition of an interest in the underlying technology of the ZRx Prescriber from Quebec-based ZoomMed Inc. Financial details have not been disclosed.

ZoomMed Inc. is a publicly traded company (TSXV: ZMD) that builds and operates a clinical information exchange platform between physicians, pharmacists and the various other stakeholders of the Health sector with whom they interact. The company has the largest private network of electronic prescriptions and drug information system in Canada.

TELUS Health is a leader in telehomecare, electronic medical and health records, consumer health, benefits management and pharmacy management. TELUS Health solutions give health authorities, providers, physicians, patients and consumers the power to turn information into better health outcomes. It is an operating subsidiary of TELUS (TSX: T), one of Canada’s largest telecommunication companies.

“This acquisition builds upon our EMR leadership position and claims and benefits expertise, and allows us to have a more direct and positive impact on the patient experience, which ultimately leads to better health outcomes for Canadians,” said Paul Lepage, President of TELUS Health.

Oaklins' team in Montreal advised the seller in this transaction.

Parties prenantes

Contacter l'équipe de la transaction

Sebastien Nadeau

Associé directeur
Montréal, Canada
Oaklins Canada

Fausto Levy

Chef de la direction
Montréal, Canada
Oaklins Canada

Transactions connexes

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Soins de la Santé

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

En apprendre plus
Rare Patient Voice has been acquired by Konovo
Soins de la Santé | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

En apprendre plus
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Soins de la Santé

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

En apprendre plus